5 March 2024 - PDUFA set to 21 October 2024. ...
4 March 2024 - Formosa Pharmaceuticals and AimMax Therapeutics announced today that the US FDA has approved clobetasol propionate 0.05% ...
5 March 2024 - Ellipses Pharma announced today that it has received fast track designation from the US FDA for its ...
4 March 2024 - The manufacturers of 10 high cost drugs selected for the US Medicare program's first-ever pricing negotiations ...
5 March 2024 - Wyost (denosumab-bddz) and Jubbonti (denosumab-bddz) interchangeable with and approved by FDA for all indications of reference ...
4 March 2024 - The new PDUFA action date set by the FDA is 21 September 2024. ...
4 March 2024 - SpringWorks Therapeutics announced today that the Company has initiated a rolling submission of a new drug application ...
1 March 2024 - A federal judge in Delaware on Friday ruled against AstraZeneca in a case challenging the constitutionality ...
3 March 2024 - Hugel becomes the first and only Korean company that have market approvals in all three major aesthetic ...
1 March 2024 - Today, the FDA approved amivantamab-vmjw (Rybrevant, Janssen) with carboplatin and pemetrexed for the first-line treatment of ...
29 February 2024 - FDA has assigned a PDUFA target action date of 15 October 2024. ...
29 February 2024 - Continuing the ongoing implementation of President Biden’s prescription drug pricing law, the Inflation Reduction Act of 2022, ...
29 February 2024 - Highly differentiated allogeneic natural killer cell therapy in Phase 1 trial, with initial data expected in second ...
29 February 2024 - Two proposals to weaken Medicare’s drug price negotiation program are getting a hearing before a House Energy ...
28 February 2024 - We have a serious problem of affordability of health care in the US, including the cost of ...